GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

sorfequiline   Click here for help

GtoPdb Ligand ID: 13132

Synonyms: compound 46 [PMID: 30803745] | TBAJ-876
PDB Ligand
Compound class: Synthetic organic
Comment: Sorfequiline (previously known as TBAJ-876), an analogue of bedaquiline, was discovered at the University of Auckland following a lead optimization project to identify novel members of the diarylquinolines class of antibacterial compounds [5]. Sorfequiline has a more favourable ADME profile, lower risk of QT prolongation, and more potent antimycobacterial activity than bedaquiline [5]. See also our entry for TBAJ-587 that was identified in the same study.
Structure match for the INN sorfequiline is included in WHO proposed list 134 (Feb 2026).
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 11
Hydrogen bond donors 1
Rotatable bonds 13
Topological polar surface area 115.93
Molecular weight 657.55
XLogP 0.94
No. Lipinski's rules broken 3

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN(C)CC[C@@](C1=CC(=NC(=C1)OC)OC)([C@H](C2=C(C(=NC(=C2)OC)OC)OC)C3=C(N=C4C=CC(=CC4=C3)Br)OC)O
Isomeric SMILES CN(C)CC[C@@](C1=CC(=NC(=C1)OC)OC)([C@H](C2=CC(=NC(=C2OC)OC)OC)C3=C(N=C4C=CC(=CC4=C3)Br)OC)O
InChI InChI=1S/C31H37BrN4O7/c1-36(2)12-11-31(37,19-15-24(38-3)34-25(16-19)39-4)27(21-17-26(40-5)35-30(43-8)28(21)41-6)22-14-18-13-20(32)9-10-23(18)33-29(22)42-7/h9-10,13-17,27,37H,11-12H2,1-8H3/t27-,31-/m1/s1
InChI Key HHDDKDPLFXIPBX-DLFZDVPBSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
The MIC90 against Mycobacterium tuberculosis H37Rv (under replicating conditions in vitro) is 4 ng/ml for sorfequiline compared to 40 ng/ml for bedaquiline [5]. Sorfequiline also has potent in vitro and in vivo activity against M. abscessus [4].